First International Commercial Flight Completed With Newly Approved Amyris-Total Aviation Biofuel
July 31 2014 - 1:52PM
Yesterday, Amyris (Nasdaq:AMRS), an industrial bioscience company,
partnered with Brazilian airline, GOL, to fly the industry's first
commercial flight with farnesane, the recently approved renewable
jet fuel. The first flight, GOL flight 7725, departed from Orlando,
Florida on July 30, 2014 at 5:15 PM ET and traveled to Sao Paulo,
Brazil.
The Amyris website includes video footage and photos of the
refueling using the Amyris-Total renewable jet fuel, departure of
the flight and photography of the aircraft.
GOL committed to fly its Boeing 737 fleet with up to a 10
percent blend of the renewable farnesane fuel starting with this
initial flight on July 30, 2014. Farnesane can reduce greenhouse
gas (GHG) emissions by up to 80 percent compared to petroleum
fuels. When blended with Jet A/A1 fuel at 10 percent, farnesane can
also reduce particulate matter emissions, decreasing pollution near
airports and major metropolitan areas.
The global aviation industry has committed to aggressive goals
to reduce its GHG emissions, including achieving carbon neutral
growth by 2020 and reducing emissions by 50 percent by 2050
compared to 2005. In addition to improving the efficiency of
airplanes and flight operations, this renewable biofuel represents
a major opportunity for commercial aviation to reduce emissions.
The approved renewable jet fuel is drop-in and can be blended
directly with petroleum jet fuel without any changes to airplanes,
engines or fueling infrastructure. Amyris will now begin to
quantitatively measure the positive impact to GHG emissions and air
quality with every flight using the renewable jet fuel.
About the Companies
Amyris is an integrated renewable products
company focused on providing sustainable alternatives to a broad
range of petroleum-sourced products. Amyris uses its industrial
bioscience technology platform to convert plant sugars into a
variety of hydrocarbon molecules -- flexible building blocks that
can be used in a wide range of products. Amyris is commercializing
these products both as No Compromise® renewable ingredients in
cosmetics, flavors and fragrances, polymers, lubricants and
consumer products, and also as No Compromise renewable diesel and
jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the
establishment and expansion of Amyris's production in Brazil. More
information about Amyris is available at www.amyris.com.
GOL Linhas Aéreas Inteligentes S.A.
(Bovespa:GOLL4) and (NYSE:GOL), the largest low-cost and low-fare
airline in Latin America, offers around 910 daily flights to 67
destinations in 15 countries in South America, the Caribbean and
the United States under the GOL and VARIG brands, using a young,
modern fleet of Boeing 737-700 and 737-800. The SMILES loyalty
program allows members to accumulate miles and redeem tickets to
more than 560 locations around the world via flights with foreign
partner airlines. The Company also operates Gollog, a logistics
service which retrieves and delivers cargo and packages to and from
more than 3,500 cities in Brazil and six abroad. With its portfolio
of innovative products and services, GOL Linhas Aéreas Inteligentes
offers the best cost-benefit ratio in the market. More information
about GOL is available at www.voegol.com
Amyris Forward-Looking Statements
This release contains forward-looking statements, and any
statements other than statements of historical facts could be
deemed to be forward-looking statements. These forward-looking
statements include, among other things, statements regarding future
events (including additional commercial flights using Amyris-Total
aviation biofuel and the performance and benefits of such fuel for
the aviation industry and environment) that involve risks and
uncertainties. These statements are based on management's current
expectations and actual results and future events may differ
materially due to risks and uncertainties, including those
associated with Amyris's reliance on third parties to achieve its
goals, competition, delays or failures in product adoption or
acceptance by customers, and other risks detailed in the "Risk
Factors" section of Amyris's quarterly report on Form 10-Q filed on
May 9, 2014. Amyris disclaims any obligation to update information
contained in these forward-looking statements whether as a result
of new information, future events, or otherwise.
Amyris, the Amyris logo and No Compromise are trademarks or
registered trademarks of Amyris, Inc. All other trademarks are the
property of their respective owners.
CONTACT: Amyris
Joel Velasco, Senior Vice President
+1 (510) 740-7481
info@amyris.com
GOL
Semayat Oliveira
Comunicacao Corporativa/Analista
Corporativo: +55 11 2128.4429 Ramal: 4429
ssoliveira@golnaweb.com.br
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From Sep 2023 to Sep 2024